spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  {prev}
EVENTS FOR 2018
{next}  
   
 
EVENTS FOR ALL MAGAZINES
 
     

ChinaBio Partnering Forum 2018

25-26 April 2018
Kempinski Hotel Suzhou, Jiangsu, China

Access a world of opportunities through life science partnering in China. ChinaBio® Partnering Forum is the premier life science partnering event in China. The conference will be held April 25–26 in Suzhou, attracting biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. More>>

 
phone +1 760 930 0500
email conferences@ebdgroup.com
web bit.ly/2BjVHpU
email Kempinski Hotel Suzhou, China
 

Temperature Controlled Logistics in Biopharmaceuticals USA 2018

24-25 April 2018
Princeton, USA

After an extremely successful first edition, Temperature Controlled Logistics in Biopharmaceuticals is back in Princeton in April 2018! More>>

 
 

BioTrinity 2018

23-25 April 2018
Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies. More>>

 
 

BioProcess International European Summit

23-25 April 2018
RAI, Amsterdam

Bringing together 900+ attendees from all major departments in bioprocessing: Cell Culture, Downstream, Manufacturing, Vaccines, Viral Safety and Cell Line Development this April in Amsterdam, Europe’s largest bioprocessing event BPI Europe 2018 will provide you with the latest advice on how optimise bioprocessing through connecting science, technology and business. More>>

 
 

Viral Safety and Raw Materials

23-25 April 2018
RAI, Amsterdam

Viral Safety and Raw Materials 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. More>>

 
phone +44 (0) 20 3377 3279
email LS.Registrations@Knect365.com
web bit.ly/2BLft1E
email RAI, Amsterdam
 

Vaccine Manufacturing

23-25 April 2018
RAI, Amsterdam

Changing the shape of vaccine development, manufacturing and delivery. More>>

 
phone +44 (0) 20 3377 3279
email LS.Registrations@Knect365.com
web bit.ly/2sOjJdI
email RAI, Amsterdam
 

Cell Line Development and Engineering

23-25 April 2018
RAI, Amsterdam

Cell Line Development & Engineering 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. More>>

 
 

INTERPHEX 2018

17-18 April 2018
Javits Center, New York, USA

At INTERPHEX, find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by Parenteral Drug Association (PDA). More>>

 
phone (203) 840-5455
email KScott@reedexpo.com
web bit.ly/2ET106L
email Javits Center, New York, USA
 

5th Annual Peptides Congress 2018

16-17 April 2018
Novotel London West Hotel, Hammersmith, London

Oxford Global Conferences are proud to present our highly anticipated 5th Annual Peptides Congress, 16th– 17th April 2018, London, UK. Over 450 peptides, proteins and antibodies attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. More>>

 
 

11th Annual Proteins & Antibodies Congress

16-17 April 2018
Novotel London West Hotel, Hammersmith, London

Oxford Global Conferences are proud to present our esteemed 11thAnnual Proteins & Antibodies Congress 2018, 16th – 17th April 2018, London, UK. Over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. More>>

 
 

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018
Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th – 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics More>>

 
 

LogiPharma Europe 2018

10-12 April 2018
Montreux Music & Convention Centre

Now in it’s 18th successful year, LogiPharma is the largest global end-to-end supply chain event for pharma supply chain leaders, their teams and service partners. More>>

 
phone 44 (0) 20 7368 9854
email logipharma@wbr.co.uk
web bit.ly/2mhwYgC
email Montreux Music & Convention Centre, Switzerland
 

IRT Europe Summit

10-11 April 2018
The Hotel Brussels, Belgium

New clinical trial regulations are requiring sponsors to keep tighter oversight than ever before – from audit trails to tracking system changes – resulting in high costs and trial delays. IRT Europe explores implementation best practices and how interactive response technologies can be utilised to improve supply chain planning and optimise clinical trials. More>>

 
phone +1-339-298-2127
email Thomas.Zekos@cbinet.com
web www.cbinet.com/IRTEU
email The Hotel Brussels, Belgium
 

Adaptive Designs in Clinical Trials

9-10 April 2018
Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

Now running for 10 years, SMi’s annual conference on Adaptive Designs in Clinical Trials will return to London on 9thand 10th April 2018. This year’s agenda has been curated to provide you with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development. More>>

 
 
spacer
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>


News and Press Releases

Significant improvement in overall survival with ERLEADA®▼ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer

BEERSE, BELGIUM, May 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA®▼ (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Programme (Abstract #5516) beginning on Friday 29th May.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement